Two Sequoia Fund Directors Quit on Valeant Position

The managers of the $7.2 billion Sequoia Fund have agreed not to buy more shares of Valeant Pharmaceuticals International Inc. after the three remaining independent directors on the fund’s board expressed concern that the position had grown too big, the New York Times reported. Bloomberg's Peggy Collins reports on "Bloomberg Markets." (Source: Bloomberg)

Rep. Peter Roskam Looking for Simpler Tax System
12:16 - Bloomberg News reporter Sahil Kapur spoke with Representative Peter Roskam on the pitch for a historic overhaul of the U.S. tax code. However, efforts were overshadowed by President Trump's comments that equated white supremacists and counter-protesters in Charlottesville, Virginia. (Source: Bloomberg)
  • Rep. Peter Roskam Says Trump Comments are Not Acceptable
  • Nikesh Arora on Ride-Hailing Companies, Uber's Future
  • Full Show: Bloomberg Technology (08/16)